Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, offering promising breakthroughs across a variety of healthcare and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, far more dependable substitute for therapeutic